Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism IL-17 inhibitors(Interleukin-17 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |